Feb. 14, 2011 (Canada NewsWire Group) --
TORONTO, Feb. 14 /CNW/ - DELISTING REVIEW - SemBioSys Genetics Inc. (the "Company") - Further to TSX Bulletin 2010-1423 dated December 2, 2010, TSX has extended its review of the eligibility of the common shares of the Company (Symbol: SBS) for continued listing for a period of 30 days.
About TMX Group
TMX Group's key subsidiaries operate cash and derivative markets for multiple asset classes including equities, fixed income and energy. Toronto Stock Exchange, TSX Venture Exchange, Montreal Exchange, Natural Gas Exchange, Boston Options Exchange (BOX), Shorcan, Equicom and other TMX Group companies provide trading markets, clearing facilities, data products and other services to the global financial community. TMX Group is headquartered in Toronto with offices in Montreal, Calgary and Vancouver. For more information about TMX Group, visit our website at www.tmx.com.
Corporate Communications, TMX Group Inc., Toll Free 1-888-873-8392, info@tsx.com
